Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF204P is a transcribed pseudogene possibly derived from ZNF79, encoding a predicted protein that would be severely truncated and lack key domains such as the KRAB domain and the C2H2 type zinc finger domain required for DNA binding and transcriptional regulation. Thus, ZNF204P does not produce a functional zinc finger protein and is not considered a molecular target for drug development or therapy. It is weakly linked to some cancer phenotypes through genetic association studies, but its biological function is unclear and it is not directly implicated as a protein-coding gene in disease mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 204, pseudogene (ZNF204P).